Patients tolerate mRNA COVID-19 vaccines despite hypersensitivity to taxanes - Healio

6/17/2022 12:00:00 AM2 years 10 months ago

Patients with a history of mild to moderate hypersensitivity reactions to taxanes safely received the mRNA vaccines for COVID-19, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice. This research is the largest safe…

Patients with a history of mild to moderate hypersensitivity reactions to taxanes safely received the mRNA vaccines for COVID-19, according to a study published in The Journal of Allergy and Clinical… [+4478 chars]

full article...